Get this price down, Joe!
In a release, Lilly said Zepbound should be available in the U.S. by the end of the year. It will carry a list price of about $1,060 for a month's supply.
The cost may put the new drug out of reach for many people given that insurance companies are often reluctant to cover weight loss medications, and Medicare, by law, does not cover them.
"The current cost is too expensive for the general population," Dr. Nishant Shah, a preventative cardiologist at Duke University Medical Center in Durham, North Carolina. "We have to be able to get to patients in an affordable way."
In the United States, 4 in 10 adults have obesity, according to the Centers for Disease Control and Prevention.
Although the drug carries a steep price, some analysts have anticipated it will become the best-selling drug in history.
https://www.msn.com/en-us/health/other/fda-approves-weight-loss-drug-from-eli-lilly-that-helped-people-lose-up-to-52-pounds/ar-AA1jBAI0?ocid=msedgntp&pc=HCTS&cvid=be97bfadaba24b338d7172aa91b96a58&ei=3